AFT Pharmaceuticals (AFT Pharmaceuticals) Total Assets : $100.52 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals Total Assets?

AFT Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 was $100.52 Mil.

Warning Sign:

If a company builds assets at 21.4% a year, faster than its revenue growth rate of 14.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, AFT Pharmaceuticals's average Total Assets Growth Rate was 6.90% per year. During the past 3 years, the average Total Assets Growth Rate was 14.60% per year. During the past 5 years, the average Total Assets Growth Rate was 21.40% per year.

During the past 9 years, AFT Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 26.90%. The lowest was 14.60%. And the median was 22.60%.

Total Assets is connected with ROA %. AFT Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 was 34.46%. Total Assets is also linked to Revenue through Asset Turnover. AFT Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 was 0.70.

AFT Pharmaceuticals Total Assets Historical Data

The historical data trend for AFT Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Total Assets Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

Get a 7-Day Free Trial

52.73

75.04

83.63

91.91

100.52

AFT Pharmaceuticals Quarterly Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Total Assets	Get a 7-Day Free Trial												83.63	74.74	91.91	94.23	100.52

AFT Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

AFT Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	53.403	+	47.118
	=	100.52

AFT Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	53.403	+	47.118
	=	100.52

AFT Pharmaceuticals (OTCPK:AFTPF) Total Assets Explanation

Total Assets is connected with ROA %.

AFT Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	33.56	/	( (94.23	+	100.521)	/ 2 )
	=	33.56	/	97.3755
	=	34.46 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

AFT Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	67.867	/	( (94.23	+	100.521)	/ 2 )
=	67.867	/	97.3755
=	0.70

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

AFT Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (AFT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand AFP:Australia

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.